[Federal Register Volume 72, Number 14 (Tuesday, January 23, 2007)]
[Notices]
[Page 2907]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-851]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 20, 2006, Organix 
Inc., 240 Salem Street, Woburn, Massachusetts 01801, made application 
by letter to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of Tetrahydrocannabinols (7370), a basic class 
of controlled substance listed in schedule II.
    The company plans on manufacturing this controlled substance for 
sale to its customers. These customers will sell the drug in small 
quantities for research purposes or as drug standards for forensic 
laboratories.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative/ODL; or any being sent via express mail should be sent 
to DEA Headquarters, Attention: DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must 
be filed no later than March 26, 2007.

     Dated: January 16, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-851 Filed 1-22-07; 8:45 am]
BILLING CODE 4410-09-P